Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Peptic Ulcer

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    December 2025
  1. NOH Y, Choi A, Lee H, Yon DK, et al
    Proton pump inhibitors use and risk of inflammatory bowel disease in children.
    Gut. 2025 Dec 31:gutjnl-2025-337345. doi: 10.1136/gutjnl-2025-337345.
    PubMed    


    November 2025
  2. NIGAM GB, Oakland K, Hearnshaw S, Grasnt-Casey J, et al
    Acute upper gastrointestinal bleeding in the UK: 2022 audit update.
    Gut. 2025 Nov 19:gutjnl-2025-335134. doi: 10.1136/gutjnl-2025-335134.
    PubMed     Abstract available


  3. WANG Y, Lu C, Liang Z, Weng D, et al
    Does the benefit of haemostatic powder differ by Forrest classification in non-variceal upper gastrointestinal bleeding?
    Gut. 2025 Nov 17:gutjnl-2025-337421. doi: 10.1136/gutjnl-2025-337421.
    PubMed    


    October 2025
  4. LEUNG WK, Ang TL, Shah S, Cheung KS, et al
    Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditions.
    Gut. 2025 Oct 7:gutjnl-2025-335823. doi: 10.1136/gutjnl-2025-335823.
    PubMed     Abstract available


    September 2025
  5. LIOU JM, Malfertheiner P, Hong TC, Cheng HC, et al
    Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II.
    Gut. 2025 Sep 5:gutjnl-2025-336027. doi: 10.1136/gutjnl-2025-336027.
    PubMed     Abstract available


    July 2025
  6. SCHULZ C, Liou JM, Alboraie M, Bornschein J, et al
    Helicobacter pylori antibiotic resistance: a global challenge in search of solutions.
    Gut. 2025 Jul 11:gutjnl-2025-335523. doi: 10.1136/gutjnl-2025-335523.
    PubMed     Abstract available


    June 2025
  7. GONG R, Huang B, Ralser A, Friedrich V, et al
    CagA-dependent Hobit(+) gastric tissue-resident memory T cells confer full protection from Helicobacter pylori reinfection.
    Gut. 2025 Jun 5:gutjnl-2025-334781. doi: 10.1136/gutjnl-2025-334781.
    PubMed     Abstract available


    May 2025
  8. SHIN J, Cha B, Hong J, Kwon KS, et al
    Prevention of rebleeding after primary haemostasis using haemostatic powder in non-variceal upper gastrointestinal bleeding: a multicentre randomised controlled trial.
    Gut. 2025 May 13:gutjnl-2024-332459. doi: 10.1136/gutjnl-2024-332459.
    PubMed     Abstract available


    April 2025
  9. LEE YC
    Single-biopsy epigenetic profiling reveals persistent DNA methylation and gastric cancer risk after Helicobacter pylori eradication.
    Gut. 2025 Apr 23:gutjnl-2025-335329. doi: 10.1136/gutjnl-2025-335329.
    PubMed    


    October 2024
  10. OLMEDO L, Calvet X, Gene E, Bordin DS, et al
    Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).
    Gut. 2024 Oct 26:gutjnl-2024-332804. doi: 10.1136/gutjnl-2024-332804.
    PubMed     Abstract available


    August 2024
  11. LIU Z, Hong J, He F
    Letter to the editor: Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2024 Aug 29:gutjnl-2024-333604. doi: 10.1136/gutjnl-2024-333604.
    PubMed    


    July 2024
  12. ZHANG Q, Dunbar KB, Odze RD, Agoston AT, et al
    Hypoxia-inducible factor-1alpha mediates reflux-induced epithelial-mesenchymal plasticity in Barrett's oesophagus patients.
    Gut. 2024;73:1269-1279.
    PubMed     Abstract available


    June 2024
  13. GAO W, Liu J, Wang X, Li J, et al
    Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy.
    Gut. 2024 Jun 21:gutjnl-2024-332640. doi: 10.1136/gutjnl-2024-332640.
    PubMed     Abstract available


    May 2024
  14. YUAN S, Larsson SC, Gill D, Burgess S, et al
    Concerns about instrumental variable selection for biological effect versus uptake of proton pump inhibitors in Mendelian randomisation analysis.
    Gut. 2024 May 2:gutjnl-2024-332280. doi: 10.1136/gutjnl-2024-332280.
    PubMed    


    April 2024
  15. DUTTA AK, Sharma V, Jain A, Elhence A, et al
    Inappropriate use of proton pump inhibitors in clinical practice globally: a systematic review and meta-analysis.
    Gut. 2024 Apr 26:gutjnl-2024-332154. doi: 10.1136/gutjnl-2024-332154.
    PubMed    


    March 2024
  16. BOECKXSTAENS G, Elsen S, Belmans A, Annese V, et al
    10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy.
    Gut. 2024;73:582-589.
    PubMed     Abstract available


    February 2024
  17. AN H, Zhong M, Gan H
    Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study.
    Gut. 2024 Feb 15:gutjnl-2024-331904. doi: 10.1136/gutjnl-2024-331904.
    PubMed    


    January 2024
  18. XIAO X, Zhang X, Wang J, Liu Y, et al
    Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
    Gut. 2024 Jan 24:gutjnl-2023-330883. doi: 10.1136/gutjnl-2023-330883.
    PubMed    


  19. BLACK CJ, Paine PA, Ford AC
    Letter to the editor: Helicobacter pylori eradication, the proof is not in the symptoms-authors' reply.
    Gut. 2024 Jan 12:gutjnl-2024-331892. doi: 10.1136/gutjnl-2024-331892.
    PubMed    


    December 2023
  20. NARENDREN A, Tsoi AH, Iqbal A, Glance S, et al
    Rare complication of peptic ulcer disease.
    Gut. 2023 Dec 12:gutjnl-2023-330867. doi: 10.1136/gutjnl-2023-330867.
    PubMed    


  21. TOH DE, Lo SW, Tsoi A, Segal JP, et al
    Right tool for the right bleeder.
    Gut. 2023;73:206-207.
    PubMed    


    November 2023
  22. ZHU J, Sun C, Li M, Hu G, et al
    Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Gut. 2023 Nov 22:gutjnl-2023-330168. doi: 10.1136/gutjnl-2023-330168.
    PubMed     Abstract available


  23. LUO S, Ru J, Khan Mirzaei M, Xue J, et al
    Helicobacter pylori infection alters gut virome by expanding temperate phages linked to increased risk of colorectal cancer.
    Gut. 2023 Nov 2:gutjnl-2023-330362. doi: 10.1136/gutjnl-2023-330362.
    PubMed    


    September 2023
  24. LIU BD, Udemba SC, Liang K, Tarabichi Y, et al
    Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort st
    Gut. 2023 Sep 22:gutjnl-2023-329651. doi: 10.1136/gutjnl-2023-329651.
    PubMed     Abstract available


    July 2023

  25. Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
    Gut. 2023 Jul 19:gutjnl-2022-329259. doi: 10.1136/gutjnl-2022-329259.
    PubMed     Abstract available


    June 2023
  26. SJOMINA O, Vangravs R, Leonova E, Polaka I, et al
    Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut.
    Gut. 2023 Jun 26:gutjnl-2023-329792. doi: 10.1136/gutjnl-2023-329792.
    PubMed    


    May 2023
  27. ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al
    Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052.
    PubMed    


  28. LEI WY, Lee JY, Chuang SL, Bair MJ, et al
    Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
    Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871.
    PubMed     Abstract available


    April 2023
  29. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    PubMed     Abstract available


  30. YE BD
    Proton pump inhibitors and the risk of inflammatory bowel disease: cause, protopathic bias or others?
    Gut. 2023 Apr 4:gutjnl-2023-329506. doi: 10.1136/gutjnl-2023-329506.
    PubMed    


    March 2023
  31. CHEN PY, Tsai FP, Chen MJ, Yang HY, et al
    Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials.
    Gut. 2023 Mar 31:gutjnl-2023-329826. doi: 10.1136/gutjnl-2023-329826.
    PubMed    


  32. ZHANG J, Deng Y, Liu C, Wang H, et al
    'Family-based' strategy for Helicobacter pylori infection screening: an efficient alternative to 'test and treat' strategy.
    Gut. 2023 Mar 7:gutjnl-2023-329696. doi: 10.1136/gutjnl-2023-329696.
    PubMed    


  33. MALFERTHEINER P, Megraud F, Rokkas T, Gisbert JP, et al
    Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point.
    Gut. 2023 Mar 6:gutjnl-2023-329712. doi: 10.1136/gutjnl-2023-329712.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.